Pfizer is likely to sell its animal health division by way of a slump sale to its wholly owned subsidiary (being incorporated) in consideration of approximately Rs. 440,00,00,000, subject to adjustment for working capital, to be paid by the wholly owned subsidiary either in cash and/or by issue of shares at par or premium.
The company has received formal approval from board of directors for the sale of healthcare business at its meeting held on February 6, 2012. This development is part of a global internal re-organization taken up by its parent, Pfizer Inc in July 2011, under which the firm was reviewing strategic alternatives for its global animal health business.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: